Medinomics Health Care
Home Profile Commitment Mission Strength Contact Us Sitemap
News & Events

Bioequivalence study confirms that our artemether with lumefantrine combination is BIOEQUIVALENT to Coartem.

Malmed and Fantem range launched in Ghana

Malmed and Fantem range launched in Malawi.

Have launch OTC products under Ocean Health & Medical Pvt Ltd in a joint venture with foreign partners.

Completed stability studies for 14 days after reconstitution of FANTEM Suspension ( Artemether 180 with Lumefantrine 1080 ).

Registration of various our antimalarial products is in final stages of approval in FRANCOPHONE COUNTRIES.

Kenya Fantem tablets and Suspension is scheduled to be launched in the month of March 2009.

Fantem range launched in Zambia.

 
Infrastructure
 

Infrastructure

With two state of the art manufacturing plants in India, MEDINOMICS is ideally positioned to meet the forthcoming challenges and requirements in the globalised economy of world's healthcare sector.

GMP Standards

A devoted, well knit manufacturing team is employed, who will continuously improve and innovate methods and processes beyond the requirements of who GMP.

Quality policy

At MEDINOMICS commitment to quality and innovation is very certain. our products reflects the quality assurance and care of competent, dedicated personnel, who have quality close to their hearts every team member has built an attitude of perfection and this helps us in meeting the global demand  of excellence  in quality.

Quality Assurance Team


MEDINOMICS has a dedicated team of competent quality assurance employees, comprised of dependable task force people, who feels quality close to their heart.

Quality Assurance Department

Quality assurance department is equipped with modern and automated equipment that aid in enforcing rigid standards.

 
 
© 2010 Medinomics. All Rights Reserved.